Clinical Trials Directory

Trials / Unknown

UnknownNCT05749107

In-depth Characterization of Atriogenic Secondary Tricuspid Regurgitation Due to Atrial Fibrillation

In-depth Characterization of Atriogenic Secondary Tricuspid Regurgitation Due to Atrial Fibrillation. Prevalence, Mechanisms, Advanced Quantification of Regurgitation Severity, and Relative Impact of Sinus Rhythm Restoration on the 3D Remodeling of Right Heart Chambers and Tricuspid Valve Apparatus

Status
Unknown
Phase
Study type
Observational
Enrollment
1,050 (estimated)
Sponsor
Istituto Auxologico Italiano · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

1050 patients with persistent/permanent atrial fibrillation (AF) will be studied using conventional and advanced (three-dimensional and deformation imaging) echocardiography. Patients with moderate/severe isolated secondary tricuspid regurgitation (STR) will undergo blood tests to assess their proteomic profile and cardiac CT to measure the tricuspid annulus geometry. The project will aim to 1. assess the prevalence of moderate/severe isolated STR in patients with AF; 2. identify the mechanisms associated with the development of moderate-severe STR in patients with AF; 3. identify the proteomic profile associated with significant growth of tricuspid valve leaflets as a mechanism to protect patients with AF from the development of moderate/severe STR; 4. evaluate the effects of the restoration of sinus rhythm on the severity of STR and the remodeling of the right heart cardiac structures (i.e. right ventricle, right atrium, and tricuspid valve apparatus).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEchocardiographyIdentify AF patients at risk of developing moderate/severe STR and those who will benefit from restoring the normal sinus rhythm
COMBINATION_PRODUCTProteomic analysesTo identify the mechanisms leading to moderate/severe STR during AF.

Timeline

Start date
2022-12-02
Primary completion
2024-12-02
Completion
2025-11-02
First posted
2023-03-01
Last updated
2024-03-15

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT05749107. Inclusion in this directory is not an endorsement.